BOGOTA, Colombia – After seven years of continuous work developing a strategic alliance with Cuban scientists, Roswell Park Comprehensive Cancer Center (RPCCC) in Buffalo, N.Y., has created a joint venture with the Havana-based Center for Molecular Immunology to bring the Cimavax vaccine to American lung cancer patients.

BOGOTA, Colombia – Regulatory environments for the registration of generics and biosimilars have improved in the last few years, but a lack of consistency among countries has created challenges for drugmakers.

BOGOTA, Colombia – With an investment of more than $30 million in its new Bthek Biotecnologia development and production plant, Brazilian biopharma company União Química Farmacêutica Nacional SA is boosting its presence in the Latin American biotech market.

BOGOTA, Colombia – Montevideo, Uruguay-based Grupo Biotoscana (GBT) is moving forward with the acquisition of an Argentine company even as it released weak results for the third quarter.

BOGOTA, Colombia – Efforts to streamline and speed up drug approvals in Colombia are proving effective, with a new committee focused on new molecules and biologics moving applications forward at a rapid pace.